Nanotech Systems, Inc. said Tuesday that it has appointed Dr. Terrance Owen as Chief Executive Officer, effective May 1, 2012.
Dr. Owen is the co-founder and has been the President and CEO of ALDA Pharmaceuticals Corp., which has developed novel, patented, OTC infection control therapeutics for topical use, since 2000. From 1980 to 2002, he was the President of Helix Biotech , which provided DNA testing services forpaternity, immigration and forensic cases across Canada. From 1995 to 1998, he was also the President of Helix BioPharma Corp.
Dr. Owen has 25 years of executive experience with publicly-traded life sciences companies in Canada and the US. He will be responsible for maintaining Nanotech's listing on the Frankfurt Stock Exchange, which is eliminating its First Quotation Board and requiring companies to meet the Entry Standard listing requirements by December 15,2012.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.